No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

被引：0
|
作者：
Malene Hove-Skovsgaard
Julie Abildgaard
Marco Gelpi
Julie Christine Gaardbo
Lilian Kolte
Henrik Ullum
Marius Trøseid
Birgitte Lindegaard
Susanne Dam Nielsen
机构：
[1] Copenhagen University Hospital,Department of Infectious Diseases, Rigshospitalet
[2] University of Copenhagen,The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet
[3] University of Copenhagen,Department of Infectious Diseases, Hvidovre Hospital
[4] University of Copenhagen,Department of Pulmonary
[5] Copenhagen University Hospital, and Infectious Diseases, Nordsjællands Hospital
[6] Oslo University Hospital,Department of Clinical Immunology, Rigshospitalet
[7] Oslo University Hospital,Section of Clinical Immunology and Infectious Diseases
[8] Institute for Clinical Medicine,Research Institute of Internal Medicine
[9] University of Oslo,undefined
来源：
BMC Infectious Diseases | / 20卷
关键词：
HIV infection; Diabetes mellitus type 2; Fat distribution; Adiponectin; IL-6; sCD14;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers
    Hove-Skovsgaard, Malene
    Abildgaard, Julie
    Gelpi, Marco
    Gaardbo, Julie Christine
    Kolte, Lilian
    Ullum, Henrik
    Troseid, Marius
    Lindegaard, Birgitte
    Nielsen, Susanne Dam
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [2] Plasma concentration of inflammatory markers and adiponectin in patients with type 2 diabetes mellitus
    Zurawska-Klis, M
    Drzewoski, J
    DIABETES, 2005, 54 : A544 - A545
  • [3] The Level of Inflammatory Markers and Their Relationship with Fat Tissue Distribution in Children with Obesity and Type 2 Diabetes Mellitus
    Erturk, Beyza Akalin
    Gulbahar, Ozlem
    Sahap, Seda Kaynak
    Bulut, Tuba Saadet Deveci
    Cetinkaya, Semra
    Erdeve, Senay Savas
    TURKISH ARCHIVES OF PEDIATRICS, 2023, 58 (05): : 485 - 493
  • [4] Inflammatory markers and control of type 2 diabetes mellitus
    Elimam, Hanan
    Abdulla, Azza M.
    Taha, Inas Mohamed
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 800 - 804
  • [5] Visfatin and adiponectin as early markers of atherosclerosis in type 2 diabetes mellitus
    Ibtissam Zakaria
    Mary N. Rizk
    Maha Rakha
    Amal Shehaby
    The Egyptian Journal of Internal Medicine, 2013, 25 (3) : 143 - 148
  • [6] Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus
    Swellam, Menha
    Mahmoud, Magda Sayed
    Ali, Adel Abdel-Fatah
    DISEASE MARKERS, 2009, 27 (06) : 269 - 278
  • [7] Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian
    Krakoff, J
    Funahashi, T
    Stehouwer, CDA
    Schalkwijk, CG
    Tanaka, S
    Matsuzawa, Y
    Kobes, S
    Tataranni, PA
    Hanson, RL
    Knowler, WC
    Lindsay, RS
    DIABETES CARE, 2003, 26 (06) : 1745 - 1751
  • [8] HIV Infection Is Associated With Type 2 Diabetes Mellitus
    Hogh, Julie
    Gelpi, Marco
    Hove-Skovsgaard, Malene
    Afzal, Shoaib
    Nordestgaard, Borge G.
    Gerstoft, Jan
    Benfield, Thomas
    Storgaard, Heidi
    Nielsen, Susanne D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (04) : E32 - E35
  • [9] Plasma adiponectin concentration and insulin resistance in type 2 diabetes mellitus
    Kim, M
    Lee, Y
    Chung, C
    OBESITY RESEARCH, 2004, 12 : A182 - A182
  • [10] Plasma adiponectin and insulin resistance in Korean type 2 diabetes Mellitus
    Kim, MJ
    Yoo, KH
    Park, HS
    Chung, SM
    Jin, CJ
    Lee, Y
    Shin, YG
    Chung, CH
    YONSEI MEDICAL JOURNAL, 2005, 46 (01) : 42 - 50
12345